UMN Pharma Inc. develops and manufactures biopharmaceuticals in Japan and internationally. It develops UMN-0502, a seasonal influenza vaccine; UMN-0501 and UMN-0901, which are pandemic influenza vaccines; UMN-2003, a norovirus/rotavirus vaccine; and UMN-2002, a norovirus vaccine. The company was founded in 2004 and is headquartered in Yokohama, Japan.
umn pharma inc
(4585:Tokyo Stock Exchange)
The Landmark Tower Yokohama
2-2-1 Minato Mirai
Phone: 81 45 263 9200
Fax: 81 45 263 9205www.umnpharma.com/en
|No competitor information is available for 4585.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact UMN PHARMA INC, please visit www.umnpharma.com/en. Company data is provided by Capital IQ. Please use this form to report any data issues.